Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The role of NS1-specific antibodies in the pathogenesis of dengue virus infection is poorly understood. Here we investigate the immunoglobulin responses of patients with dengue fever (DF) and dengue hemorrhagic fever (DHF) to NS1. Antibody responses to recombinant-NS1 are assessed in serum samples throughout illness of patients with acute secondary DENV1 and DENV2 infection by ELISA. NS1 antibody titres are significantly higher in patients with DHF compared to those with DF for both serotypes, during the critical phase of illness. Furthermore, during both acute secondary DENV1 and DENV2 infection, the antibody repertoire of DF and DHF patients is directed towards distinct regions of the NS1 protein. In addition, healthy individuals, with past non-severe dengue infection have a similar antibody repertoire as those with mild acute infection (DF). Therefore, antibodies that target specific NS1 epitopes could predict disease severity and be of potential benefit in aiding vaccine and treatment design.

Original publication

DOI

10.1038/s41467-018-07667-z

Type

Journal article

Journal

Nat Commun

Publication Date

07/12/2018

Volume

9

Keywords

Amino Acid Sequence, Antibodies, Viral, Antibody Formation, Antigens, Viral, Cross Reactions, Dengue, Dengue Virus, Humans, Peptides, Sequence Homology, Amino Acid, Serogroup, Severe Dengue, Viral Nonstructural Proteins, Virulence, West Nile virus